IBDEI07N ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10045,1,4,0)
 ;;=4^374.14
 ;;^UTILITY(U,$J,358.3,10045,2)
 ;;=Edctropion, Cicatricial^269089
 ;;^UTILITY(U,$J,358.3,10046,0)
 ;;=374.12^^72^688^14
 ;;^UTILITY(U,$J,358.3,10046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10046,1,3,0)
 ;;=3^Ectropion, Mechanical
 ;;^UTILITY(U,$J,358.3,10046,1,4,0)
 ;;=4^374.12
 ;;^UTILITY(U,$J,358.3,10046,2)
 ;;=Ectropion, Mechanical^269085
 ;;^UTILITY(U,$J,358.3,10047,0)
 ;;=374.13^^72^688^16
 ;;^UTILITY(U,$J,358.3,10047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10047,1,3,0)
 ;;=3^Ectropion, Spastic
 ;;^UTILITY(U,$J,358.3,10047,1,4,0)
 ;;=4^374.13
 ;;^UTILITY(U,$J,358.3,10047,2)
 ;;=Ectropion, Spastic^269087
 ;;^UTILITY(U,$J,358.3,10048,0)
 ;;=374.00^^72^688^22
 ;;^UTILITY(U,$J,358.3,10048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10048,1,3,0)
 ;;=3^Entropion, Unspec
 ;;^UTILITY(U,$J,358.3,10048,1,4,0)
 ;;=4^374.00
 ;;^UTILITY(U,$J,358.3,10048,2)
 ;;=Entropion, Unspec^41016
 ;;^UTILITY(U,$J,358.3,10049,0)
 ;;=374.04^^72^688^18
 ;;^UTILITY(U,$J,358.3,10049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10049,1,3,0)
 ;;=3^Entropion, Cicatricial
 ;;^UTILITY(U,$J,358.3,10049,1,4,0)
 ;;=4^374.04
 ;;^UTILITY(U,$J,358.3,10049,2)
 ;;=Entropion, Cicatricial^269080
 ;;^UTILITY(U,$J,358.3,10050,0)
 ;;=374.02^^72^688^19
 ;;^UTILITY(U,$J,358.3,10050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10050,1,3,0)
 ;;=3^Entropion, Mechanical
 ;;^UTILITY(U,$J,358.3,10050,1,4,0)
 ;;=4^374.02
 ;;^UTILITY(U,$J,358.3,10050,2)
 ;;=Entropion, Mechanical^269076
 ;;^UTILITY(U,$J,358.3,10051,0)
 ;;=374.03^^72^688^21
 ;;^UTILITY(U,$J,358.3,10051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10051,1,3,0)
 ;;=3^Entropion, Spastic
 ;;^UTILITY(U,$J,358.3,10051,1,4,0)
 ;;=4^374.03
 ;;^UTILITY(U,$J,358.3,10051,2)
 ;;=Spastic Entropion^269078
 ;;^UTILITY(U,$J,358.3,10052,0)
 ;;=870.0^^72^688^58
 ;;^UTILITY(U,$J,358.3,10052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10052,1,3,0)
 ;;=3^Eyelid/Periocular Skin Laceration
 ;;^UTILITY(U,$J,358.3,10052,1,4,0)
 ;;=4^870.0
 ;;^UTILITY(U,$J,358.3,10052,2)
 ;;=Laceration, Eyelid^274879
 ;;^UTILITY(U,$J,358.3,10053,0)
 ;;=374.20^^72^688^72
 ;;^UTILITY(U,$J,358.3,10053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10053,1,3,0)
 ;;=3^Lagophthalmos
 ;;^UTILITY(U,$J,358.3,10053,1,4,0)
 ;;=4^374.20
 ;;^UTILITY(U,$J,358.3,10053,2)
 ;;=Lagophthalmos^265452
 ;;^UTILITY(U,$J,358.3,10054,0)
 ;;=378.9^^72^688^98
 ;;^UTILITY(U,$J,358.3,10054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10054,1,3,0)
 ;;=3^Strabismus
 ;;^UTILITY(U,$J,358.3,10054,1,4,0)
 ;;=4^378.9
 ;;^UTILITY(U,$J,358.3,10054,2)
 ;;=Strabismus^123833
 ;;^UTILITY(U,$J,358.3,10055,0)
 ;;=242.90^^72^688^99
 ;;^UTILITY(U,$J,358.3,10055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10055,1,3,0)
 ;;=3^Thyrotoxicosis w/o Crisis Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,10055,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,10055,2)
 ;;=Thyroid Eye Disease^267811^376.21
 ;;^UTILITY(U,$J,358.3,10056,0)
 ;;=374.05^^72^688^100
 ;;^UTILITY(U,$J,358.3,10056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10056,1,3,0)
 ;;=3^Trichiasis w/o Entropion
 ;;^UTILITY(U,$J,358.3,10056,1,4,0)
 ;;=4^374.05
 ;;^UTILITY(U,$J,358.3,10056,2)
 ;;=Trichiasis^269082
 ;;^UTILITY(U,$J,358.3,10057,0)
 ;;=375.21^^72^688^69
 ;;^UTILITY(U,$J,358.3,10057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10057,1,3,0)
 ;;=3^Lacrimal,Epiphora,Excess
 ;;^UTILITY(U,$J,358.3,10057,1,4,0)
 ;;=4^375.21
 ;;^UTILITY(U,$J,358.3,10057,2)
 ;;=Epiphora, excess lacrimation^269137
 ;;^UTILITY(U,$J,358.3,10058,0)
 ;;=375.22^^72^688^23
 ;;^UTILITY(U,$J,358.3,10058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10058,1,3,0)
 ;;=3^Epiphora, Insuff Drainage
 ;;^UTILITY(U,$J,358.3,10058,1,4,0)
 ;;=4^375.22
 ;;^UTILITY(U,$J,358.3,10058,2)
 ;;=Epiphora, Insuff Drainage^269138
 ;;^UTILITY(U,$J,358.3,10059,0)
 ;;=375.53^^72^688^67
 ;;^UTILITY(U,$J,358.3,10059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10059,1,3,0)
 ;;=3^Lacrimal,Canal Stenosis
 ;;^UTILITY(U,$J,358.3,10059,1,4,0)
 ;;=4^375.53
 ;;^UTILITY(U,$J,358.3,10059,2)
 ;;=Lacrimal Canal Stenosis^269154
 ;;^UTILITY(U,$J,358.3,10060,0)
 ;;=375.51^^72^688^70
 ;;^UTILITY(U,$J,358.3,10060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10060,1,3,0)
 ;;=3^Lacrimal,Punctum Eversion
 ;;^UTILITY(U,$J,358.3,10060,1,4,0)
 ;;=4^375.51
 ;;^UTILITY(U,$J,358.3,10060,2)
 ;;=Lacrimal Punctum Eversion^269150
 ;;^UTILITY(U,$J,358.3,10061,0)
 ;;=375.54^^72^688^71
 ;;^UTILITY(U,$J,358.3,10061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10061,1,3,0)
 ;;=3^Lacrimal,Sac Stenosis
 ;;^UTILITY(U,$J,358.3,10061,1,4,0)
 ;;=4^375.54
 ;;^UTILITY(U,$J,358.3,10061,2)
 ;;=Lacrimal Punctum Stenosis^269156
 ;;^UTILITY(U,$J,358.3,10062,0)
 ;;=375.56^^72^688^78
 ;;^UTILITY(U,$J,358.3,10062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10062,1,3,0)
 ;;=3^Nasolacrimal Duct Obstruction
 ;;^UTILITY(U,$J,358.3,10062,1,4,0)
 ;;=4^375.56
 ;;^UTILITY(U,$J,358.3,10062,2)
 ;;=Obstruction, Nasolacrimal duct^269159
 ;;^UTILITY(U,$J,358.3,10063,0)
 ;;=376.30^^72^688^87
 ;;^UTILITY(U,$J,358.3,10063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10063,1,3,0)
 ;;=3^Orbit Exophalmos
 ;;^UTILITY(U,$J,358.3,10063,1,4,0)
 ;;=4^376.30
 ;;^UTILITY(U,$J,358.3,10063,2)
 ;;=Exophthalmos^43683
 ;;^UTILITY(U,$J,358.3,10064,0)
 ;;=802.8^^72^688^88
 ;;^UTILITY(U,$J,358.3,10064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10064,1,3,0)
 ;;=3^Orbit Fracture
 ;;^UTILITY(U,$J,358.3,10064,1,4,0)
 ;;=4^802.8
 ;;^UTILITY(U,$J,358.3,10064,2)
 ;;=Fracture of Orbit^25315
 ;;^UTILITY(U,$J,358.3,10065,0)
 ;;=870.4^^72^688^92
 ;;^UTILITY(U,$J,358.3,10065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10065,1,3,0)
 ;;=3^Orbit Penetrating Wound w/ Foreign Body
 ;;^UTILITY(U,$J,358.3,10065,1,4,0)
 ;;=4^870.4
 ;;^UTILITY(U,$J,358.3,10065,2)
 ;;=Foreign Body in Orbit^274883
 ;;^UTILITY(U,$J,358.3,10066,0)
 ;;=376.10^^72^688^91
 ;;^UTILITY(U,$J,358.3,10066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10066,1,3,0)
 ;;=3^Orbit Inflammation,Chronic
 ;;^UTILITY(U,$J,358.3,10066,1,4,0)
 ;;=4^376.10
 ;;^UTILITY(U,$J,358.3,10066,2)
 ;;=Orbital Inflammation^269175
 ;;^UTILITY(U,$J,358.3,10067,0)
 ;;=360.41^^72^688^66
 ;;^UTILITY(U,$J,358.3,10067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10067,1,3,0)
 ;;=3^Hypotensive Blind Phthisis,Blind
 ;;^UTILITY(U,$J,358.3,10067,1,4,0)
 ;;=4^360.41
 ;;^UTILITY(U,$J,358.3,10067,2)
 ;;=Phthisis^268564
 ;;^UTILITY(U,$J,358.3,10068,0)
 ;;=376.50^^72^688^86
 ;;^UTILITY(U,$J,358.3,10068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10068,1,3,0)
 ;;=3^Orbit Enopthalmos
 ;;^UTILITY(U,$J,358.3,10068,1,4,0)
 ;;=4^376.50
 ;;^UTILITY(U,$J,358.3,10068,2)
 ;;=Enopthalmos^40801
 ;;^UTILITY(U,$J,358.3,10069,0)
 ;;=239.2^^72^688^95
 ;;^UTILITY(U,$J,358.3,10069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10069,1,3,0)
 ;;=3^Orbital Tumor,Neopl,Unspec Nature
 ;;^UTILITY(U,$J,358.3,10069,1,4,0)
 ;;=4^239.2
 ;;^UTILITY(U,$J,358.3,10069,2)
 ;;=Orbital Tumor^267783
 ;;^UTILITY(U,$J,358.3,10070,0)
 ;;=239.7^^72^688^79
 ;;^UTILITY(U,$J,358.3,10070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10070,1,3,0)
 ;;=3^Optic Nerve Neop,Unspec Nature
 ;;^UTILITY(U,$J,358.3,10070,1,4,0)
 ;;=4^239.7
 ;;^UTILITY(U,$J,358.3,10070,2)
 ;;=Optic Nerve Tumor^267785
 ;;^UTILITY(U,$J,358.3,10071,0)
 ;;=V52.2^^72^688^2
 ;;^UTILITY(U,$J,358.3,10071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10071,1,3,0)
 ;;=3^Artificial Eye Prosthethic Check
 ;;^UTILITY(U,$J,358.3,10071,1,4,0)
 ;;=4^V52.2
 ;;^UTILITY(U,$J,358.3,10071,2)
 ;;=Prosthethic Eye Check^295498^V43.0
 ;;^UTILITY(U,$J,358.3,10072,0)
 ;;=173.10^^72^688^56
 ;;^UTILITY(U,$J,358.3,10072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10072,1,3,0)
 ;;=3^Eyelid/Canthus,Malig Neopl,Unspec
 ;;^UTILITY(U,$J,358.3,10072,1,4,0)
 ;;=4^173.10
 ;;^UTILITY(U,$J,358.3,10072,2)
 ;;=^340597
 ;;^UTILITY(U,$J,358.3,10073,0)
 ;;=173.11^^72^688^53
 ;;^UTILITY(U,$J,358.3,10073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10073,1,3,0)
 ;;=3^Eyelid/Canthus,BCC
 ;;^UTILITY(U,$J,358.3,10073,1,4,0)
 ;;=4^173.11
 ;;^UTILITY(U,$J,358.3,10073,2)
 ;;=^340467
 ;;^UTILITY(U,$J,358.3,10074,0)
 ;;=173.12^^72^688^57
 ;;^UTILITY(U,$J,358.3,10074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10074,1,3,0)
 ;;=3^Eyelid/Canthus,SCC
 ;;^UTILITY(U,$J,358.3,10074,1,4,0)
 ;;=4^173.12
 ;;^UTILITY(U,$J,358.3,10074,2)
 ;;=^340468
 ;;^UTILITY(U,$J,358.3,10075,0)
 ;;=173.19^^72^688^55
 ;;^UTILITY(U,$J,358.3,10075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10075,1,3,0)
 ;;=3^Eyelid/Canthus,Malig Neopl,Oth
 ;;^UTILITY(U,$J,358.3,10075,1,4,0)
 ;;=4^173.19
 ;;^UTILITY(U,$J,358.3,10075,2)
 ;;=^340469
 ;;^UTILITY(U,$J,358.3,10076,0)
 ;;=053.20^^72^688^51
 ;;^UTILITY(U,$J,358.3,10076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10076,1,3,0)
 ;;=3^Eyelid,Herpes Zoster
 ;;^UTILITY(U,$J,358.3,10076,1,4,0)
 ;;=4^053.20
 ;;^UTILITY(U,$J,358.3,10076,2)
 ;;=^56937
 ;;^UTILITY(U,$J,358.3,10077,0)
 ;;=054.41^^72^688^50
 ;;^UTILITY(U,$J,358.3,10077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10077,1,3,0)
 ;;=3^Eyelid,Herpes Simplex
 ;;^UTILITY(U,$J,358.3,10077,1,4,0)
 ;;=4^054.41
 ;;^UTILITY(U,$J,358.3,10077,2)
 ;;=^266563
 ;;^UTILITY(U,$J,358.3,10078,0)
 ;;=078.0^^72^688^77
 ;;^UTILITY(U,$J,358.3,10078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10078,1,3,0)
 ;;=3^Molluscum Contagiosum
 ;;^UTILITY(U,$J,358.3,10078,1,4,0)
 ;;=4^078.0
 ;;^UTILITY(U,$J,358.3,10078,2)
 ;;=^78675
 ;;^UTILITY(U,$J,358.3,10079,0)
 ;;=228.1^^72^688^76
 ;;^UTILITY(U,$J,358.3,10079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10079,1,3,0)
 ;;=3^Lymphangioma
 ;;^UTILITY(U,$J,358.3,10079,1,4,0)
 ;;=4^228.1
 ;;^UTILITY(U,$J,358.3,10079,2)
 ;;=^72391
 ;;^UTILITY(U,$J,358.3,10080,0)
 ;;=238.2^^72^688^3
 ;;^UTILITY(U,$J,358.3,10080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10080,1,3,0)
 ;;=3^Benign Neopl,Oth & Unspec Sites/Tissue
